Showing 41 - 60 results of 345 for search '"Alzheimer disease"', query time: 0.07s Refine Results
  1. 41

    Cerebrospinal Fluid BACE1 Activity and Brain Amyloid Load in Alzheimer's Disease by Timo Grimmer, Panagiotis Alexopoulos, Amalia Tsolakidou, Liang-Hao Guo, Gjermund Henriksen, Behrooz H. Yousefi, Hans Förstl, Christian Sorg, Alexander Kurz, Alexander Drzezga, Robert Perneczky

    Published 2012-01-01
    “…The secretase BACE1 is fundamentally involved in the development of cerebral amyloid pathology in Alzheimer's disease (AD). It has not been studied so far to what extent BACE1 activity in cerebrospinal fluid (CSF) mirrors in vivo amyloid load in AD. …”
    Get full text
    Article
  2. 42
  3. 43
  4. 44

    Polyunsaturated Fatty Acid and S-Adenosylmethionine Supplementation in Predementia Syndromes and Alzheimer's Disease: A Review by Francesco Panza, Vincenza Frisardi, Cristiano Capurso, Alessia D'Introno, Anna M. Colacicco, Alessandra Di Palo, Bruno P. Imbimbo, Gianluigi Vendemiale, Antonio Capurso, Vincenzo Solfrizzi

    Published 2009-01-01
    “…In this review article, we focus on dietary supplementation suggested for predementia syndromes and Alzheimers disease (AD), with particular emphasis on S-adenosylmethionine (SAM) and polyunsaturated fatty acids (PUFA). …”
    Get full text
    Article
  5. 45

    The use of virtual reality in screening for preclinical Alzheimer's disease: A scoping review protocol. by Yuan Tian, Maneesh V Kuruvilla, Mira Park

    Published 2023-01-01
    “…<h4>Introduction</h4>Preclinical Alzheimer's disease (AD) represents the earliest phase of AD, often years before the onset of mild cognitive impairment (MCI). …”
    Get full text
    Article
  6. 46

    Zinc Metalloproteinases and Amyloid Beta-Peptide Metabolism: The Positive Side of Proteolysis in Alzheimer's Disease by Mallory Gough, Catherine Parr-Sturgess, Edward Parkin

    Published 2011-01-01
    “…Alzheimer's disease is a neurodegenerative condition characterized by an accumulation of toxic amyloid beta- (A𝛽-)peptides in the brain causing progressive neuronal death. …”
    Get full text
    Article
  7. 47

    Detection of Alzheimer Disease in Neuroimages Using Vision Transformers: Systematic Review and Meta-Analysis by Vivens Mubonanyikuzo, Hongjie Yan, Temitope Emmanuel Komolafe, Liang Zhou, Tao Wu, Nizhuan Wang

    Published 2025-02-01
    “… BackgroundAlzheimer disease (AD) is a progressive condition characterized by cognitive decline and memory loss. …”
    Get full text
    Article
  8. 48
  9. 49
  10. 50
  11. 51

    Mitochondrial- and Endoplasmic Reticulum-Associated Oxidative Stress in Alzheimer's Disease: From Pathogenesis to Biomarkers by E. Ferreiro, I. Baldeiras, I. L. Ferreira, R. O. Costa, A. C. Rego, C. F. Pereira, C. R. Oliveira

    Published 2012-01-01
    “…Alzheimer's disease (AD) is the most common cause of dementia in the elderly, affecting several million of people worldwide. …”
    Get full text
    Article
  12. 52

    Oxidative Stress and Hypoxia Contribute to Alzheimer's Disease Pathogenesis: Two Sides of the Same Coin by Michela Guglielmotto, Elena Tamagno, Oliviero Danni

    Published 2009-01-01
    “…While it is well established that stroke and cerebral hypoperfusion are risk factors for Alzheimer's disease (AD), the molecular link between ischemia/hypoxia and amyloid precursor protein (APP) processing has only been recently established. …”
    Get full text
    Article
  13. 53

    Why is the New York Times Writing so Much about Alzheimer's Disease Therapies? by Tamas Bartfai

    Published 2010-01-01
    “…Can we go back to proving that drugs work in preventing, postponing, and ameliorating familial Alzheimer's disease (ad)? Ad is so devastating that there is a great public interest in the drug discovery process as evinced by the sheer number of articles in the serious popular press. …”
    Get full text
    Article
  14. 54

    Patient stratification by genetic risk in Alzheimer's disease is only effective in the presence of phenotypic heterogeneity. by Jack Euesden, Muhammad Ali, Chloe Robins, Praveen Surendran, Padhraig Gormley, Alzheimer’s Disease Neuroimaging Initiative (ADNI), David Pulford, Carlos Cruchaga

    Published 2025-01-01
    “…This is particularly relevant in Alzheimer's disease (AD), where longitudinal cohorts measure disease "progression," defined by rate of cognitive decline. …”
    Get full text
    Article
  15. 55
  16. 56
  17. 57
  18. 58
  19. 59
  20. 60

    Introducing an ensemble method for the early detection of Alzheimer's disease through the analysis of PET scan images by Arezoo Borji, Taha-Hossein Hejazi, Abbas Seifi

    Published 2025-03-01
    “…Alzheimer's Disease (AD) is a progressive neurodegenerative disorder that primarily affects cognitive functions such as memory, thinking, and behavior. …”
    Get full text
    Article